Know Cancer

or
forgot password

Collection of Blood, Tissue and Urine From Patients With Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Neoplasms

Thank you

Trial Information

Collection of Blood, Tissue and Urine From Patients With Cancer


Patients with a prior diagnosis of malignancy or refractory cancer will be evaluated in the
Medical Oncology Clinic, NCI or Interventional Radiology, NIH Clinical Center. Blood or
urine samples may be collected at the initial visit and at follow-up visits. The specimens
will be processed and stored in one or more of these locations for use in research efforts:
Laboratory of Tumor Immunology and Biology, Clinical Pharmacology Program, NCI

Frederick, Dr. Tito Fojo's laboratory and Dr. Jane Trepel's Laboratory.

Inclusion Criteria


- INCLUSION CRITERIA:

Patients 18 years of age and older are eligible.

Patients must have a performance status of ECOG 0, 1, 2, or 3 for admission to this
protocol.

Patients with malignancy are eligible.

INCLUSION FOR APHERESIS:

Hemoglobin greater than or equal to 10 mg/dL and platelet count > 75,000/mm(3)

Weight greater than 25 kg

HIV negative

Prothrombin Time - within normal limits

Partial Thromboplastin Time - within normal limits

Medically indicated central line in place or adequate peripheral venous access

EXCLUSION CRITERIA:

Children will not be eligible.

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

James L Gulley, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)

Authority:

United States: Federal Government

Study ID:

020179

NCT ID:

NCT00034216

Start Date:

April 2002

Completion Date:

Related Keywords:

  • Neoplasms
  • Suppressor Cells
  • T Cells
  • CD4+/CD25+ Cells
  • Cancer
  • Malignancy
  • Blood Sample
  • Neoplasms

Name

Location

National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, Maryland  20892